1. Panossian A, Wikman G. Pharmacology of
Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharmacol. 2008; 118:183–212.
Article
2. He XG, Lian LZ, Lin LZ. Analysis of lignan constituents from
Schisandra chinensis by liquid chromatography-electrospray mass spectrometry. J Chromatogr. 1997; 757:81–87.
Article
3. Kim EY, Baek IH, Rhyu MR. Cardioprotective effects of aqueous
Schizandra chinensis fruit extract on ovariectomized and balloon-induced carotid artery injury rat models: effects on serum lipid profiles and blood pressure. J Ethnopharmacol. 2011; 134:668–675.
Article
4. Hikino H, Kiso Y, Taguchi H, Ikeya Y. Antihepatotoxic actions of lignoids from Schizandra chinensis fruits. Planta medica. 1984; 50:213–218.
5. Hu D, Cao Y, He R, Han N, Liu Z, Miao L, Yin J. Schizandrin, an antioxidant lignan from Schisandra chinensis, ameliorates Aβ1-42-induced memory impairment in mice. Oxid Med Cell Longev. 2012; 2012:721721.
6. Kang S, Lee KP, Park SJ, Noh DY, Kim JM, Moon HR, Lee YG, Choi YW, Im DS. Identification of a novel anti-inflammatory compound, α-cubebenoate from
Schisandra chinensis. J Ethnopharmacol. 2014; 153:242–249.
Article
7. Han DH, Lee JH, Kim H, Ko MK, Chae MR, Kim HK, So I, Jeon JH, Park JK, Lee SW. Effects of
Schisandra chinensis extract on the contractility of corpus cavernosal smooth muscle (CSM) and Ca2+ homeostasis in CSM cells. BJU Int. 2012; 109:1404–1413.
Article
8. Liu W, Choi BR, Bak YO, Zhang LT, Zhou LX, Huang YR, Zhao C, Park JK. Cavernosum smooth muscle relaxation induced by Schisandrol A via the NO-cGMP signaling pathway. Cell Mol Biol. 2016; 62:115–119.
9. Wespes E, Amar E, Hatzichristou D, Montorsi F, Pryor J, Vardi Y. Guidelines on erectile dysfunction. Eur Urol. 2002; 41:1–5.
Article
10. Cho YJ, Hwang HS, Park HK, Jeong JG. Prevalence of erectile dysfunction and utilization of sexual counseling in community family medicine clinics. Korean J Fam Med. 2009; 30:617–625.
Article
11. Lee JH, Choi JK, Kim SH, Cho KH, Kim YT, Choi SH, Jung UW. Association between periodontal flap surgery for periodontitis and vasculogenic erectile dysfunction in Koreans. J Periodontal Implant Sci. 2017; 47:96–105.
Article
12. Ghalayini IF. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility. Int J Impot Res. 2004; 16:459–469.
Article
13. Paul V, Ekambaram P. Involvement of nitric oxide in learning & memory processes. Indian J Med Res. 2011; 133:471–478.
14. Nunes KP, Webb RC. Mechanisms in erectile function and dysfunction: an overview. erectile dysfunction-disease-associated mechanisms and novel insights into therapy. InTech;2012. p. 4–10.
15. Toque HA, Caldwell RW. New approaches to the design and discovery of therapies to prevent erectile dysfunction. Expert Opin Drug Discov. 2014; 9:1447–1469.
Article
16. Recio P, López PG, Hernández M, Prieto D, Contreras J, Garcí a-Sacristán A. Nitrergic relaxation of the horse corpus cavernosum. Role of cGMP. Eur J Pharmacol. 1998; 351:85–94.
Article
17. Zhang G, Liu Y, Ruoho AE, Hurley JH. Structure of the adenylyl cyclase catalytic core. Nature. 1997; 386:247–253.
Article
18. Rhyu M, Kim EY, Yoon BK, Lee Y, Chen SN. Aqueous extract of
Schizandra chinensis fruit causes endothelium-dependent and-independent relaxation of isolated rat thoracic aorta. Phytomedicine. 2006; 13:651–657.
Article
19. Zhao C, Chae HJ, Kim SH, Cui WS, Lee SW, Jeon JH, Park JK. A new perfusion model for studying erectile function. J Sex Med. 2010; 7:1419–1428.
Article
20. Cui X, Lee SJ, Kim SZ, Kim SH, Cho KW. Effects of pituitary adenylate cyclase activating polypeptide27 on cyclic AMP efflux and atrial dynamics in perfused beating atria. Eur J Pharmacol. 2000; 402:129–137.
Article
21. Kim HK, Bak YO, Choi BR, Zhao C, Lee HJ, Kim CY, Lee SW, Jeon JH, Park JK. The role of the lignan constituents in the effect of
Schisandra chinensis fruit extract on penile erection. Phytother Res. 2011; 25:1776–1782.
Article
22. Seok YM, Choi YW, Kim GD, Kim HY, Takuwa Y, Kim IK. Effects of gomisin A on vascular contraction in rat aortic rings. Naunyn Schmiedebergs Arch Pharmacol. 2011; 383:45–56.
Article
23. Park JY, Lee SJ, Yun MR, Seo KW, Bae SS, Park JW, Lee YJ, Shin WJ, Choi YW, Kim CD. Gomisin A from
Schisandra chinensis induces endothelium-dependent and direct relaxation in rat thoracic aorta. Planta medica. 2007; 73:1537–1542.
Article
24. McMahon C. Erectile dysfunction. Intern Med J. 2014; 44:18–26.
Article
25. Kandeel FR, Koussa VK, Swerdloff RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev. 2001; 22:342–388.
Article
26. Gonzalez-Cadavid NF, Rajfer J. The pleiotropic effects of inducible nitric oxide synthase (iNOS) on the physiology and pathology of penile erection. Curr Pharm Des. 2005; 11:4041–4046.
Article
27. Haas CA, Seftel AD, Razmjouei K, Ganz MB, Hampel N, Ferguson K. Erectile dysfunction in aging: upregulation of endothelial nitric oxide synthase. Urology. 1998; 51:516–522.
Article
28. Park JY, Shin HK, Lee YJ, Choi YW, Bae SS, Kim CD. The mechanism of vasorelaxation induced by
Schisandra chinensis extract in rat thoracic aorta. J Ethnopharmacol. 2009; 121:69–73.
Article
29. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, Vardi Y. EAU Guidelines on erectile dysfunction: an update. Eur Urol. 2006; 49:806–815.
Article
30. Huang SA, Lie JD. Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction. P T. 2013; 38:407.
31. DeBusk RF, Pepine CJ, Glasser DB, Shpilsky A, DeRiesthal H, Sweeney M. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am J Cardiol. 2004; 93:147–153.
Article
32. Wachtel H. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology. 1983; 22:267–272.
Article
33. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev. 1995; 75:725–748.
Article